EBMT NEWSLETTER | November 2015 | Volume 49 - Issue 1

EBMT
Important dates

EBMT abstracts at ASH

The EBMT will be actively participating to the 57th American Society of Hematology Meeting that will be held December 5-8, in Orlando, Florida.

The EBMT will present 39 communications in the different oral or posters sessions.
You will find below the list of these abstracts including title, time and location of presentations. You can click on the title to view the full abstract from the ASH website.

Congratulations to all co-authors and thank you all for your continuous support!

---


Hematopoietic Stem Cell Transplantation from HLA Identical Sibling Forsickle Cell Disease an International Survey on Behalf of Eurocord-Monacord, EBMT Paediatric Disease Working Party and CIBMTR
Type: Paper
Number: 541
Presenter: Barbara Cappelli
Program: Oral and Poster Abstracts
Session: 114. Hemoglobinopathies, Excluding Thalassemia – Clinical: Promising Therapies in Sickle Cell Disease
Time and Location:
Monday, December 7, 2015: 10:30 AM-12:00 PM
W340 (Orange County Convention Center) 
 
Development and Preliminary Usability and Accuracy Testing of the EBMT Gvhd App to Support Graft Versus Host Disease Diagnosis and Scoring According to NIH Criteria, By the EBMT Complications and Quality of Life Working Party
Type: Paper
Number: 3151
Presenter: Rafael Duarte
Program: Oral and Poster Abstracts
Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II
Time and Location:
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 

Alternative Donors (Umbilical Cord Blood and Haploidentical Donors) for Allogeneic Stem Cell Transplantation in Relapsed / Refractory Hodgkin Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party and the Spanish Group of Stem Cell Transplantation (GETH)
Type: Paper
Number: 4399
Presenter: Carmen Martinez
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 
 
An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT
Type: Paper
Number: 1929
Presenter: Attilio Bondanza
Program: Oral and Poster Abstracts
Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I
Time and Location:
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A (Orange County Convention Center) 
 
Efficacy, Safety and Long Term Results of Prophylactic and Preemptive Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Acute Leukemia: A Registry-Based Evaluation on 343 Patients By the Acute Leukemia Working Party of EBMT
Type: Paper
Number: 863
Presenter: Christoph Schmid
Program: Oral and Poster Abstracts
Session: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Relapse
Time and Location:
Monday, December 7, 2015: 4:30 PM-6:00 PM
Tangerine 2 (WF2) (Orange County Convention Center) 

Comparison of Matched-Sibling Donors Versus Unrelated Donors in Allogeneic Stem Cell Transplantation (allo-SCT) for Primary Refractory Acute Myeloid Leukemia (PRF AML): A Report of 1041 Patients from the Acute Leukemia Working Party of the EBMT
Type: Paper
Number: 196
Presenter: Eolia Brissot
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Matched Related, Unrelated, and Alternative Donor Allograft Outcomes for Myeloid and Lymphoid Malignancies
Time and Location:
Sunday, December 6, 2015: 7:30 AM-9:00 AM
W304 (Orange County Convention Center) 

Refined Disease Risk Index (DRI) and Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Predict Survival after Haploidentical Stem Cell Transplantation: A Comparative Study with EBMT Risk Score in 220 Consecutive Patients
Type: Paper
Number: 4400
Presenter: Maria Teresa Lupo-Stanghellini
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 
 
Outcome of Patients with Myelofibrosis Relapsing after Allogeneic Stem Cell Transplant: A Retrospective Study By the Chronic Malignancies Working Party of EBMT
Type: Paper
Number: 1958
Presenter: Donal McLornan
Program: Oral and Poster Abstracts
Session: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I
Time and Location:
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A (Orange County Convention Center) 
 
Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Type: Paper
Number: 63
Presenter: Bipin Savani
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results I
Time and Location:
Saturday, December 5, 2015: 9:30 AM-11:00 AM
W304 (Orange County Convention Center) 
 
Allogeneic Hematopoietic Cell Transplantation (HCT) for Advanced Mycosis Fungoides and Sezary Syndrome (MF/SS): Impact of Increasing the Use of Unrelated Donors (UD) - the EBMT Lymphoma Working Party Experience
Type: Paper
Number: 4403
Presenter: Rafael Duarte
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 

Impact of HLA of Winning Cord Blood Unit on Outcomes after Double Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee Cellular Therapy and Immunobiology Working Party and the Acute Leukemia Working Party of the EBMT
Type: Paper
Number: 3111
Presenter: Federica Giannotti
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster II
Time and Location:
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center)  
 
A Machine Learning Based Model to Predict Two-Year Leukemia Free Survival in Cord Blood Transplantation for Acute Leukemia - a Data Mining Study, on Behalf of Eurocord, Cord Blood Committee and the Acute Leukemia Working Party of the EBMT
Type: Paper
Number: 3211
Presenter: Roni Shouval
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 
 
Allogeneic Stem Cell Transplantation for MDS Patients More Than 70 Years of Age: a Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT
Type: Paper
Number: 4390
Presenter: Silke Heidenreich
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 

Impact of Different In Vivo T Cell Depletion Strategies on Outcomes Following Hematopoietic Stem Cell Transplantation for Idiopathic Aplastic Anaemia: A Study on Behalf of the EBMT SAA Working Party
Type: Paper
Number: 1210
Presenter: Antonio Risitano
Program: Oral and Poster Abstracts
Session: 508. Bone Marrow Failure: Poster I
Time and Location:
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A (Orange County Convention Center) 
 
Allogeneic Hematopoietic Cell Transplantation for Adult Patients with ALL: Current Results and Prognostic Factors. an Analysis from Acute Leukemia Working Party of the EBMT
Type: Paper
Number: 3202
Presenter: Sebastian Giebel
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 
 
Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Inherited or Acquired Bone Marrow Failure Disorders: A Report from Eurocord, Cord Blood Committee (CBC-CTIWP) and Severe Aplastic Anemia Working Party (SAAWP) of the European Group of Blood and Bone Marrow Transplantation (EBMT)
Type: Paper
Number: 153
Presenter: Simona Pagliuca
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results II
Time and Location:
Saturday, December 5, 2015: 4:00 PM-5:30 PM
W304 (Orange County Convention Center) 

Outcome of BONE Marrow Transplantation in Congenital Diskeratosis: Preliminary DATA from the European Group for BONE Marrow Transplantation (EBMT)
Type: Paper
Number: 3623
Presenter: Francesca Fioredda
Program: Oral and Poster Abstracts
Session: 508. Bone Marrow Failure: Poster III
Time and Location:
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 
 
Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission : Better Outcome Following Busulfan and Melphalan Compared to Busulfan and Cyclophosphamide : A Retrospective Study from the Acute Leukemia Working Party of the EBMT
Type: Paper
Number: 926
Presenter: Norbert Gorin
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results III
Time and Location:
Monday, December 7, 2015: 6:15 PM-7:45 PM
W314 (Orange County Convention Center) 

HLA Disparities Impact on Outcomes after Unmanipulated Haploidentical Hematopoietic Stem Cells Transplantation (HaploSCT) in Acute Leukemia: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Type: Paper
Number: 399
Presenter: Francesca Lorentino
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: New Insights Into the Biology of Allogeneic Transplantation 
Time and Location:
Sunday, December 6, 2015: 4:30 PM-6:00 PM
Tangerine 3 (WF3-4) (Orange County Convention Center) 

Allogeneic Stem Cell Transplantation for Elderly Patients with Intermediate-Risk Cytogenetic Acute Myeloid Leukemia and Internal Tandem Duplication of FLT3 (FLT3-ITD); A Study from the Acute Leukemia Working Party (ALWP) of the European Society of Blood and Marrow Transplantation (EBMT)
Type: Paper
Number: 4364
Presenter: Xavier Poiré
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 
 
Thiotepa-Based Conditioning for Allogeneic Stem Cell Transplantation (allo-HSCT) in Acute Lymphoblastic Leukaemia (ALL) - a Survey from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Type: Paper
Number: 4316
Presenter: Sandra Eder
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster III
Time and Location:
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 

Allogeneic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia and 17p Abnormalities in First Complete Remission: A Study from the Acute Leukemia Working Party (ALWP) of the European Society of Blood and Marrow Transplantation (EBMT)
Type: Paper
Number: 2021
Presenter: Xavier Poiré
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
Time and Location:
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A (Orange County Convention Center) 

Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with High-Risk AML in Complete Remission: A Survey from the ALWP of the EBMT
Type: Paper
Number: 3105
Presenter: Florent Malard
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster II
Time and Location:
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 
 
Comparison of Matched/Mismatched Unrelated Donor Stem Cell Transplantation to Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Type: Paper
Number: 3216
Presenter: Francesco Saraceni
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 
 
Selecting Double Cord Blood Units for Adults with Hematological Malignancies: Impact of ABO, HLA and Cell Dose on Outcomes after Double Cord Blood Transplants a CBC-Cellular Therapy & Immunobiology Working Party, EBMT and Eurocord Study
Type: Paper
Number: 3214
Presenter: Vanderson Rocha
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 
 
Autologous Transplant, and Not ATO Alone, Remains the Preferred Therapy for Relapsed APL: A Report from the CIBMTR, EBMT and Two Specialized Centers
Type: Paper
Number: 928
Presenter: Chezi Ganzel
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results III
Time and Location:
Monday, December 7, 2015: 6:15 PM-7:45 PM
W314 (Orange County Convention Center) 

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Severe Auto-Immune Disease Adult Patients: Analysis of Outcomes from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGMT-TC) in Light of the European Society for Blood and Marrow Transplantation (EBMT) Activity
Type: Paper
Number: 1985
Presenter: Perrine Guillaume-Jugnot
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results: Poster I
Time and Location:
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A (Orange County Convention Center) 
 
Allogeneic Stem Cell Transplantation for Relapsed / Refractory (R/R) Follicular Lymphoma (FL). a Joint Study Between the European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR)
Type: Paper
Number: 198
Presenter: Anna Sureda
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Matched Related, Unrelated, and Alternative Donor Allograft Outcomes for Myeloid and Lymphoid Malignancies
Time and Location:
Sunday, December 6, 2015: 7:30 AM-9:00 AM
W304 (Orange County Convention Center) 
 
Evaluation of the Impact of Non-Inherited Maternal Antigens on the Outcome of HLA Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Hematological Malignancies on Behalf of the ALWP of the EBMT and the CIBMTR
Type: Paper
Number: 3226
Presenter: Julia Pingel
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 

Very Good Response and Overall Survival after Allogeneic Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis; Results of a Non-Interventional Study By the Plasma Cell Disorder Subcommittee of the Chronic Malignancy Working Party of the EBMT
Type: Paper
Number: 4397
Presenter: Stefan Schönland
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 

Impact of CTLA4 Genotype and Other Immune Response Gene Polymorphisms on Outcomes after Umbilical Cord Blood Transplantation - a Eurocord, CBC-Ctiwb-EBMT, Netcord and FMRP-USP Study
Type: Paper
Number: 400
Presenter: Renato Cunha
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: New Insights Into the Biology of Allogeneic Transplantation 
Time and Location:
Sunday, December 6, 2015: 4:30 PM-6:00 PM
Tangerine 3 (WF3-4) (Orange County Convention Center) 
 
Outcomes of Unrelated Cord Blood Transplantation in Patients with Multiple Myeloma a Eurocord, CBC-Cellular Therapy & Immunobiology Working Party and Chronic Malignancies Working Party-EBMT Study
Type: Paper
Number: 3203
Presenter: Annalisa Paviglianiti
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 

Clinical Allogeneic Transplantation: Results: Poster II
Type: Session
Program: Oral and Poster Abstracts
Time and Location:
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 
 
Clinical Allogeneic Transplantation: Results: Poster III
Type: Session
Program: Oral and Poster Abstracts
Time and Location:
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 
 
Reduced-Intensity Versus Myeloablative Conditioning for Unrelated Cord Blood Transplantation in Adults with Acute Leukemia: A Report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy & Immunobiology Working Party of the European Group for Blood and Marrow Transplantation
Type: Paper
Number: 155
Presenter: Frederic Baron
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results II
Time and Location:
Saturday, December 5, 2015: 4:00 PM-5:30 PM
W304 (Orange County Convention Center) 
 
Allogeneic Hematopoietic Transplantation in Patients with CLL: Results of a Large Disease-Specific Risk Factor Analysis
Type: Paper
Number: 3209
Presenter: Johannes Schetelig
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center
 
The Impact of Ponatinib Versus Allogeneic Stem Cell Transplant (SCT) on Outcomes in Patients with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) with the T315I Mutation
Type: Paper
Number: 480
Presenter: Franck Nicolini
Program: Oral and Poster Abstracts
Session: 632. Chronic Myeloid Leukemia: Therapy and Prognosis
Time and Location:
Monday, December 7, 2015: 7:00 AM-8:30 AM
Valencia BC (W415BC) (Orange County Convention Center) 

The Risk of Sinusoidal Obstruction Syndrome (SOS) in Allogeneic Hematopoietic Stem Cell Transplantation after Prior Gemtuzumab Ozogamicin Treatment: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Type: Paper
Number: 3110
Presenter: Giorgia Battipaglia
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Poster II
Time and Location:
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 

Results of Allogeneic Transplantation As First Line Rescue Therapy in Patients with Multiple Myeloma Relapsing to a Prior Autograft: Role of Conditioning Regimen
Type: Paper
Number: 4373
Presenter: Jose Perez-Simon
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A (Orange County Convention Center) 
 
Bookmark and Share